Henry and Susan Samueli give $50 million to cancer research at Israel's Beilinson Hospital

At the end of April 2026, Broadcom co-founder Henry Samueli and his wife Susan announced a $50 million gift to the Samueli Integrative Cancer Pioneering Institute at Beilinson Medical Center in Petah Tikva, part of Clalit Health Services, Israel's largest health provider. Ynet reported that it is the biggest sum ever donated to an Israeli medical institution specifically for research; larger gifts to Israeli hospitals have mostly paid for buildings.

The new money builds on the couple's first gift of $25 million, which set up the institute inside the hospital's Davidoff Cancer Center a few years earlier and was supplemented by Clalit. Since then, according to eJewishPhilanthropy, the institute has opened advanced immunotherapy laboratories and moved three experimental therapies into trials with patients. The second gift will pay for recruiting leading clinicians and scientists, larger studies, new equipment and faster research operations. It will also fund the institute's approach of whole-person cancer care, which combines conventional oncology with evidence-based complementary treatments, and an artificial intelligence centre that can draw on Clalit's medical records, which cover more than half of Israel's population, to learn which patients benefit from which kinds of supportive care and when. Gal Markel, director of the Davidoff Center and chair of the institute, said the donors' main measure of success is whether its methods are adopted by other hospitals in Israel and abroad.

Henry Samueli, an engineer and former UCLA professor, co-founded the semiconductor company Broadcom in 1991. Born in the United States to Sala and Aron Samueli, Polish Jews who survived the Holocaust, he and Susan Samueli are among America's most prominent supporters of engineering education and integrative medicine, with schools at UCLA and the University of California, Irvine bearing their names, and they have also funded Holocaust education and Jewish studies.